A randomized, assessor-blind, multicentre study to investigate the efficacy and efficiency of a starting dose of 100IU or 200IU of recombinant follicle stimulating hormone (Puregon®) in women undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer treatment

✍ Scribed by S.L. Tan; T.J. Child; P. Cheung; M. Fluker; R. Casper; V. Davis

• Book ID: 119420788
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 19 KB
• Volume: 80
• Category: Article
• ISSN: 1556-5653
• DOI: 10.1016/s0015-0282(03)01394-3